JPH0723315B2 - Blood sugar elevation inhibitor - Google Patents

Blood sugar elevation inhibitor

Info

Publication number
JPH0723315B2
JPH0723315B2 JP61043391A JP4339186A JPH0723315B2 JP H0723315 B2 JPH0723315 B2 JP H0723315B2 JP 61043391 A JP61043391 A JP 61043391A JP 4339186 A JP4339186 A JP 4339186A JP H0723315 B2 JPH0723315 B2 JP H0723315B2
Authority
JP
Japan
Prior art keywords
bran
blood sugar
substance
beans
hemicellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61043391A
Other languages
Japanese (ja)
Other versions
JPS62201821A (en
Inventor
正義 菅原
政保 竹内
三郎 川村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Shokuhin Kako Co Ltd
Original Assignee
Nihon Shokuhin Kako Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Shokuhin Kako Co Ltd filed Critical Nihon Shokuhin Kako Co Ltd
Priority to JP61043391A priority Critical patent/JPH0723315B2/en
Publication of JPS62201821A publication Critical patent/JPS62201821A/en
Publication of JPH0723315B2 publication Critical patent/JPH0723315B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】 「技術分野」 本発明は、穀類、豆類の外皮より抽出されたヘミセルロ
ースを主成分とする血糖値上昇抑制物質に関する。
TECHNICAL FIELD The present invention relates to a substance for suppressing blood sugar level elevation, which is mainly composed of hemicellulose extracted from the hulls of grains and beans.

「従来技術およびその問題点」 近年、グァーガム、トラガカンタガム、ペクチン、メチ
ルセルロース、コンニャクマンナンなどが血糖値上昇抑
制作用を有するという報告がなされており、糖尿病患者
などの食事療法として注目されている。これらの高分子
物質が血糖値上昇抑制作用を有する理由は、未だ明らか
ではないが、これらの高分子物質が体内で糖を吸着し、
その吸収を阻害あるいは遅延させるためなどと考えられ
ている。
"Prior art and its problems" In recent years, it has been reported that guar gum, tragacantham gum, pectin, methylcellulose, konjak mannan and the like have an effect of suppressing an increase in blood glucose level, and has been attracting attention as a diet therapy for diabetic patients and the like. The reason why these high molecular weight substances have the effect of suppressing the increase in blood sugar level is not clear yet, but these high molecular weight substances adsorb sugar in the body,
It is considered to inhibit or delay its absorption.

しかしながら、上記の高分子物質においては、例えば粉
末のまま摂取しても有効な血糖値上昇抑制作用を得るこ
とができず、充分な効果を得るためにはゲル化させて摂
取する必要があった。ところが、これらの高分子物質
は、本来、紛体の製品として供給されているが、吸湿性
をもち、粘度が高く、水に分散させても均質なゲルにな
りにくいという難点があった。そして、ゲル化させた場
合には、一般に容積が増すので腹にたまりやすくなり、
糖尿病患者等が定期的に摂取することを困難にしてい
た。また、摂取に先立ってゲル化させなければならない
ので、取扱いも不便であった。
However, in the case of the above-mentioned polymer substances, for example, even if ingested as a powder, it is not possible to obtain an effective inhibitory effect on the rise in blood glucose level, and in order to obtain a sufficient effect, it is necessary to ingest it in a gel state. . However, although these polymer substances are originally supplied as powder products, they have the drawback that they have hygroscopicity, high viscosity, and are unlikely to form a homogeneous gel when dispersed in water. And when gelled, the volume generally increases, so it is easy to accumulate in the belly,
It has been difficult for diabetic patients to take on a regular basis. In addition, it has been inconvenient to handle because it has to be gelled before ingestion.

「発明の目的」 本発明の目的は、上記従来技術の問題点に鑑み、粉末で
も非常に水に溶けやすく、水分散性に優れ、均質な溶液
となりやすく、食べやすく、少量で効果があり、しかも
煩雑な調整を必要としない血糖値上昇抑制物質を提供す
ることにある。
"Object of the invention" The object of the present invention is, in view of the above problems of the prior art, even powder is very soluble in water, excellent in water dispersibility, easy to be a homogeneous solution, easy to eat, effective in a small amount, Moreover, it is to provide a substance for suppressing an increase in blood glucose level that does not require complicated adjustment.

「発明の構成」 本発明者らは、コーンファイバ等の食物繊維の有する生
理活性作用について長年研究を続けてきたが、その過程
で食物繊維からアルカリ抽出して得た抽出液(ヘミセル
ロースを主成分とする)が少量で顕著な血糖値上昇抑制
作用を示すことを見出し、本発明を完成するに至った。
“Structure of the Invention” The present inventors have been conducting research for many years on the physiologically active action of dietary fiber such as corn fiber. In the process, an extract obtained by alkali extraction from dietary fiber (hemicellulose is the main component). The present invention has been completed based on the finding that a small amount of the compound exhibits a remarkable inhibitory effect on blood sugar level elevation.

すなわち、本発明の血糖値上昇抑制物質は、穀類もしく
は豆類の外皮、または穀類もしくは豆類の外皮から澱粉
質、蛋白質、脂質、無機質等を除去した残部より、アル
カリ抽出してなるヘミセルロースを主成分とする。
That is, the blood sugar elevation-inhibiting substance of the present invention is the outer skin of cereals or beans, or the rest of starch or protein, lipids, minerals and the like removed from the outer skin of cereals or beans, with hemicellulose obtained by alkali extraction as the main component. To do.

本発明の血糖値上昇抑制物質は、液状、粉末いずれの状
態でも、少量服用するだけで、効果的な血糖値上昇抑制
作用を示す。したがって、取扱いが簡単で食べやすく、
実用的である。
The blood sugar level elevation-inhibiting substance of the present invention exhibits an effective blood glucose level elevation-inhibiting action by taking a small amount in either liquid or powder state. Therefore, it is easy to handle and easy to eat,
It is practical.

本発明の血糖値上昇抑制物質の原料としては、穀類もし
くは豆類の外皮が使用される。穀類の外皮としては、例
えばとうもろこしの外皮、米糠、小麦ふすま、大麦ふす
ま、はと麦ふす、カラス麦ふすま、ライ麦ふすまなどが
使用できる。また、豆類の外皮としては、例えば大豆、
小豆、えんどう豆などの外皮が使用できる。
As a raw material for the substance for suppressing blood sugar level elevation of the present invention, the outer coat of cereals or beans is used. As the outer coat of cereals, for example, the outer coat of corn, rice bran, wheat bran, barley bran, hato bran, oat bran, rye bran, etc. can be used. Also, as the hull of beans, for example, soybean,
The outer skin of red beans and peas can be used.

本発明では、これらの穀類もしくは豆類の外皮をそのま
まアルカリ抽出してもよいが、これらの穀類もしくは豆
類の外皮から澱粉質、蛋白質、脂質、無機質等を除去し
た残部を用いてアルカリ抽出した方が以後の抽出精製が
容易となるので好ましい。穀類もしくは豆類の外皮から
澱粉質、蛋白質、脂質、無機質等を除去する方法として
は、酵素処理、化学的処理、物理的処理のいずれでもよ
く、またこれらを適宜組合せて処理してもよい。酵素処
理は、例えばα−アミラーゼ、グルコアミラーゼ等の澱
粉分解酵素、プロテアーゼ等の蛋白分解酵素、リパーゼ
等の脂質分解酵素、セルラーゼ等の繊維素分解酵素をPH
3〜9、温度30〜100℃の条件下に添加作用させて処理す
ることにより行なわれる。化学的処理は、上記穀類もし
くは豆類の外皮に鉱酸、有機酸の水溶液を添加し、PH2
〜5の条件下に加熱するかまたは食品用界面活性剤を添
加し、PH3〜8の条件下に熱処理することにより行なわ
れる。物理的処理は、上記穀類もしくは豆類の外皮をホ
モジナイザー、ハンマーミル等の粉砕機で粉砕した後、
篩別することにより行なわれる。なお、穀類もしくは豆
類の外皮をそのままアルカリ抽出した後、上記のような
酵素処理、化学的処理、物理的処理を施すようにしても
よい。
In the present invention, the hulls of these cereals or beans may be alkali-extracted as they are, but it is preferable to carry out the alkali-extraction using the residue obtained by removing the starch, protein, lipid, minerals, etc. from the hulls of these cereals or beans. This is preferable because subsequent extraction and purification will be easy. The method for removing starch, proteins, lipids, minerals and the like from the hulls of cereals or beans may be any of enzymatic treatment, chemical treatment and physical treatment, or may be a combination of these treatments. Enzymatic treatment is carried out by using, for example, starch degrading enzymes such as α-amylase and glucoamylase, proteolytic enzymes such as protease, lipid degrading enzymes such as lipase, and fibrinolytic enzymes such as cellulase.
It is carried out by adding and treating under conditions of 3 to 9 and temperature of 30 to 100 ° C. Chemical treatment is carried out by adding an aqueous solution of mineral acid or organic acid to the hulls of the above-mentioned cereals or beans, and adding PH2
It is carried out by heating under the conditions of 5 to 5 or by adding a food grade surfactant and heat treating under the conditions of PH 3 to 8. Physical treatment, after crushing the outer skin of the grain or beans with a homogenizer, a crusher such as a hammer mill,
It is carried out by sieving. Alternatively, the outer skin of the grain or legume may be extracted with alkali as it is, and then subjected to the above-mentioned enzyme treatment, chemical treatment or physical treatment.

アルカリ抽出は、例えば水酸化ナトリウム水溶液などの
アルカリ水溶液を添加して混合し、非セルロース性多糖
類の区分を溶出させることによって行なわれる。本発明
の血糖値上昇抑制物質は、このアルカリ抽出液を中和し
て未精製のまま得ることもできるが、この中和物をさら
に以下のような操作で精製して得ることもできる。すな
わち、中和によって沈澱した蛋白質を遠心分離などの手
段で分離除去し、さらに必要に応じてその上澄液を透
析、エチルアルコール、イオン交換樹脂膜処理、限外
過膜処理、アルコール精製、剤処理等の単独または適
宜組合せにより精製することによって、任意の純度を有
するヘミセルローズ成分を含む本発明の血糖値上昇抑制
物質を得ることができる。
The alkali extraction is carried out by adding an alkaline aqueous solution such as an aqueous sodium hydroxide solution and mixing them to elute the non-cellulosic polysaccharides. The substance for suppressing increase in blood sugar level of the present invention can be obtained by neutralizing this alkaline extract as unpurified, or by further purifying the neutralized product by the following procedure. That is, proteins precipitated by neutralization are separated and removed by means such as centrifugation, and the supernatant is dialyzed, ethyl alcohol, ion exchange resin membrane treatment, ultrapermeabilization treatment, alcohol purification, agent The substance for suppressing an increase in blood sugar level of the present invention containing a hemicellulose component having an arbitrary purity can be obtained by purification by treatment alone or in combination as appropriate.

例えば上記のようにして得られた本発明の血糖値上昇抑
制物質は、ヘミセルロースを主成分とし、これに若干の
リグニン、セルロース、灰分等が含有されたものからな
っている。そして、少量をそのまま用いても効果的な血
糖値上昇抑制作用を示す。したがって、そのまま健康飲
食品、医薬品として利用可能であり、また、飲食品に少
量添加することにより、飲食品の風味、食感を害するこ
となく生理活性を付与することもできる。
For example, the blood sugar level elevation-inhibiting substance of the present invention obtained as described above comprises hemicellulose as a main component and a slight amount of lignin, cellulose, ash and the like contained therein. And, even if a small amount is used as it is, it shows an effective inhibitory effect on blood sugar level elevation. Therefore, it can be used as it is as a healthy food and drink or a medicine, and by adding a small amount to the food or drink, it is possible to impart physiological activity without impairing the flavor or texture of the food or drink.

「発明の実施例」 実施例1 コーンファイバ(トウモロコシ外皮)100gを5容の三
角フラスコに採る。グルコアミラーゼ(長瀬産業(株)
製、1×104GUN/g)5gを蒸留水4に溶かして紙で
過し、液に0.2M酢酸塩緩衝液(PH4.8)1を加えて
調製したグルコアミラーゼ溶液5およびトルエン数滴
を上記コーンファイバに加えて40℃で24時間保った。こ
れをガラスフィルター(151G3)で過し、残渣を水で
洗浄した後、2容三角フラスコに移し、0.5N水酸化ナ
トリウム液1を加え、容器内に窒素ガラスを充満さ
せ、ゴム栓で密栓して室温で18時間振とう(130ストロ
ーク/分)することにより、アルカリ可溶の非セルロー
ス性多糖類区分の抽出を行なった。このものを遠心分離
(3000rpm、10分)して液部を氷酢酸で中和し、トリク
ロール酢酸を最終濃度が7%になるように添加して蛋白
質を沈澱させた。沈澱物を遠心分離(5000rpm、10分)
して除去し、得られた分離液(約700ml)に水を加えて
約1.5とした後、セロファンチューブを用いて3日
間、流水中で透析した。透析内容物が中性になったのを
確認した後、約4倍量のエチルアルコール(最終濃度80
%以上)を加え、一夜放置して沈澱物を充分に生成させ
た。この沈澱物を遠心分離(4000rpm、10分)して採取
し、蒸留水1に溶解させ、凍結乾燥して淡色の本発明
品13gを得た。これを粉末とし、実験に供した。その組
成を第1表に示す。なお、組成の分析はSouthgate法に
従った。
"Examples of the Invention" Example 1 100 g of corn fiber (corn hull) is placed in a 5-volume Erlenmeyer flask. Glucoamylase (Nagase & Co., Ltd.)
(1 × 10 4 GUN / g) 5g dissolved in distilled water 4 and passed over paper, 0.2M acetate buffer solution (PH4.8) 1 was added to the solution to prepare glucoamylase solution 5 and a few drops of toluene Was added to the above cone fiber and kept at 40 ° C. for 24 hours. Pass this through a glass filter (151G3), wash the residue with water, transfer to a 2 volume Erlenmeyer flask, add 0.5N sodium hydroxide solution 1, fill the container with nitrogen glass, and seal with a rubber stopper. The alkali-soluble non-cellulosic polysaccharide fraction was extracted by shaking (130 strokes / min) at room temperature for 18 hours. This product was centrifuged (3,000 rpm, 10 minutes), the liquid part was neutralized with glacial acetic acid, and trichloracetic acid was added to a final concentration of 7% to precipitate the protein. Centrifuge the precipitate (5000 rpm, 10 minutes)
Water was added to the obtained separated liquid (about 700 ml) to make it about 1.5, and the mixture was dialyzed in running water for 3 days using a cellophane tube. After confirming that the dialysis contents became neutral, about 4 times the volume of ethyl alcohol (final concentration 80
% Or more) and allowed to stand overnight to sufficiently form a precipitate. This precipitate was collected by centrifugation (4000 rpm, 10 minutes), dissolved in distilled water 1 and freeze-dried to obtain 13 g of a light-colored product of the present invention. This was made into powder and used for the experiment. Its composition is shown in Table 1. The composition was analyzed according to the Southgate method.

実施例2 小麦ふすまを10%となるように水に投入し、これをヒス
コトロンで10分間処理した後、48meshの篩を用い、流水
でよく洗浄しながら篩分けをする。こうして得られた篩
上のふすま2部を、2%水酸化ナトリウム溶液10部に投
入し、これを撹拌しながらヘミセルロース成分を抽出す
る。抽出終了後、塩酸で中和し、遠心分離してその上澄
液を得る。この上澄液を吸着樹脂で脱色し、イオン交換
樹脂で脱塩し、さらに活性炭で処理した後、これを濃縮
して凍結乾燥を行って本発明品を得た。その組成を第2
表に示す。組成の分析は、Southgate法に従った。な
お、上記において、乾燥はスプレードライヤ、ドラムド
ライヤ等の装置を用いて行なうこともできる。
Example 2 Wheat bran was added to water so as to be 10%, treated with hyscotron for 10 minutes, and then sieved using a 48 mesh sieve while thoroughly washing with running water. 2 parts of the thus-obtained bran on a sieve are put into 10 parts of a 2% sodium hydroxide solution, and a hemicellulose component is extracted while stirring this. After completion of the extraction, the solution is neutralized with hydrochloric acid and centrifuged to obtain the supernatant. The supernatant was decolorized with an adsorption resin, desalted with an ion exchange resin, further treated with activated carbon, concentrated and freeze-dried to obtain the product of the present invention. The composition is second
Shown in the table. Compositional analysis followed the Southgate method. In the above, the drying can also be performed using a device such as a spray dryer or a drum dryer.

試験例 ラット(10週令、Wistar系、雄、体重約250g)1群4匹
を24時間絶食後、採血して空腹時血糖値を測定した。そ
の後、体重100gあたり1.25mlの試験液を経口ゾンデ針を
用いて経口投与した。経口投与後、15分、30分、60分、
120分に採血し、それぞれ血糖値を測定した。
Test Example Rats (10-week-old, Wistar system, male, body weight of about 250 g) were fasted for 24 hours, and blood was collected from the rats for 24 hours to measure the fasting blood glucose level. Then, 1.25 ml of the test solution per 100 g of body weight was orally administered using an oral probe. 15 minutes, 30 minutes, 60 minutes after oral administration,
Blood was collected at 120 minutes, and the blood glucose level was measured.

試験液は、コントロール(20%グルコース水溶液)に、
コーンヘミセルロース(実施例1)または小麦ふすまヘ
ミセルロース(実施例2)を2%溶かしたものを使用し
た。
The test solution is a control (20% glucose solution),
2% of corn hemicellulose (Example 1) or wheat bran hemicellulose (Example 2) was used.

血糖値の測定は、「デタミナ−GL−E」(商品名、協和
メデックス(株)製)を用いた酵素法によって行なっ
た。
The blood glucose level was measured by an enzymatic method using "Detamina-GL-E" (trade name, manufactured by Kyowa Medex Co., Ltd.).

この結果を第3表に示す。The results are shown in Table 3.

また、第1図はコーンヘミセルロース(実施例1)につ
いて上記結果を示したものであり、第2図は小麦ふすま
ヘミセルロース(実施例2)について上記結果を示した
ものである。第1図中、○−○はコーンヘミセルロー
ス、●−●はコントロールを示し、第2図中、○−○は
小麦ふすまヘミセルロース、●−●はコントロールを示
す。
Further, FIG. 1 shows the above results for corn hemicellulose (Example 1), and FIG. 2 shows the above results for wheat bran hemicellulose (Example 2). In FIG. 1, ○-○ indicates corn hemicellulose, ●-● indicates control, and in Fig. 2, ○-○ indicates wheat bran hemicellulose, ●-● indicates control.

第3表、第1図および第2図から、本発明によるヘミセ
ルロースを主成分とする物質は、有効な血糖値上昇抑制
作用を有していることが分る。
It can be seen from Table 3, FIG. 1 and FIG. 2 that the substance containing hemicellulose as the main component according to the present invention has an effective inhibitory effect on blood sugar level elevation.

実施例3 大豆を水に浸漬して膨潤させ、手で皮をむいて大豆外皮
を得た。この大豆外皮をホモジナイザーで処理して微粉
化した。この大豆外皮粉末を乾燥した後、0.5Nの水酸化
ナトリウム水溶液で抽出し、遠心分離して得た上澄液を
酢酸で中和した後過した。得られた分離液を限外過
膜(分画分子量10,000)を用いて濃縮、脱塩して濃縮液
を得た。この濃縮液を乾燥せずにそのまま用いて、上記
試験例と同様な試験を行なったところ、実施例1および
2の物質とほぼ同様な血糖値上昇抑制作用が確認され
た。
Example 3 Soybean was dipped in water to swell, and peeled by hand to obtain a soybean hull. This soybean hull was treated with a homogenizer and pulverized. The soybean hull powder was dried, extracted with a 0.5N aqueous sodium hydroxide solution, and centrifuged to obtain a supernatant, which was neutralized with acetic acid and then passed. The obtained separated liquid was concentrated and desalted using an ultrafiltration membrane (molecular weight cut off 10,000) to obtain a concentrated liquid. When this concentrated solution was used as it was without being dried, the same test as in the above-mentioned test example was carried out, and it was confirmed that the substances were substantially the same in inhibitory effect on blood sugar level elevation as the substances of Examples 1 and 2.

「発明の効果」 以上説明したように、本発明によれば、抽出液、濃縮液
あるいは乾燥粉末を、ゲル化等を行なわずにそのまま服
用しても、血糖値上昇抑制作用を効果的に得ることがで
きる。したがって、極めて食べやすく、取扱いも簡単と
なり、日常生活の中で容易に摂取することができる。
[Effects of the Invention] As described above, according to the present invention, even if an extract, a concentrate or a dry powder is taken as it is without gelation or the like, a blood sugar level elevation suppressing effect can be effectively obtained. be able to. Therefore, it is extremely easy to eat, easy to handle, and easily ingested in daily life.

【図面の簡単な説明】[Brief description of drawings]

第1図は本発明の実施例によって得たコーンヘミセルロ
ースを主成分とする物質の血糖値上昇抑制作用を示す図
表、第2図は本発明の他の実施例によって得た小麦ふす
まヘミセルロースを主成分とする物質の血糖値上昇抑制
作用を示す図表である。
FIG. 1 is a table showing the blood sugar level elevation inhibitory action of a substance containing corn hemicellulose as a main component obtained in the example of the present invention, and FIG. 2 is a main component of wheat bran hemicellulose obtained in another example of the present invention. 3 is a chart showing the blood sugar level elevation inhibitory action of the substance

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】穀類もしくは豆類の外皮、または穀類もし
くは豆類の外皮から澱粉質、蛋白質、脂質、無機質等を
除去した残部より、アルカリ抽出してなるヘミセルロー
スを主成分とすることを特徴とする血糖値上昇抑制物
質。
1. A blood glucose comprising hemicellulose as a main component, which is obtained by alkali-extracting the outer skin of cereals or beans, or the residue obtained by removing starches, proteins, lipids, minerals, etc. from the outer skin of cereals or beans. A substance that suppresses price increase.
【請求項2】特許請求の範囲第1項において、前記穀類
の外皮は、とうもろこしの外皮、米糖、小麦ふすま、大
麦ふすま、はと麦ふすま、カラス麦ふすま、ライ麦ふす
まより選ばれた一種である血糖値上昇抑制物質。
2. The hull of the cereal according to claim 1, which is a kind selected from corn hull, rice sugar, wheat bran, barley bran, hato bran, oat bran, and rye bran. A substance that suppresses blood sugar elevation.
【請求項3】特許請求の範囲第1項または第2項におい
て、前記豆類の外皮は、大豆、小豆またはえんどう豆の
外皮である血糖値上昇抑制物質。
3. The substance for suppressing an increase in blood glucose level according to claim 1 or 2, wherein the outer coat of the legume is the outer coat of soybean, red bean or pea.
JP61043391A 1986-02-28 1986-02-28 Blood sugar elevation inhibitor Expired - Lifetime JPH0723315B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61043391A JPH0723315B2 (en) 1986-02-28 1986-02-28 Blood sugar elevation inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61043391A JPH0723315B2 (en) 1986-02-28 1986-02-28 Blood sugar elevation inhibitor

Publications (2)

Publication Number Publication Date
JPS62201821A JPS62201821A (en) 1987-09-05
JPH0723315B2 true JPH0723315B2 (en) 1995-03-15

Family

ID=12662493

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61043391A Expired - Lifetime JPH0723315B2 (en) 1986-02-28 1986-02-28 Blood sugar elevation inhibitor

Country Status (1)

Country Link
JP (1) JPH0723315B2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01242530A (en) * 1988-03-25 1989-09-27 Nippon Shokuhin Kako Co Ltd Fatty liver suppressing substance
JPH03120227A (en) * 1989-10-02 1991-05-22 Shigeo Ochi Agent for absorbing and suppressing digested and degraded product of food and drink
CN1114438C (en) * 1997-08-29 2003-07-16 里塞克斯股份有限公司 Method for treating diabetes, hyperglycemia and hypoglycemia
WO1999011144A1 (en) 1997-09-02 1999-03-11 The Ricex Company, Inc. A method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
JP4698796B2 (en) * 2000-05-15 2011-06-08 日本食品化工株式会社 Immunostimulator
JP4846990B2 (en) * 2003-08-06 2011-12-28 株式会社テラ・ブレインズ Adiponectin secretion promoter
JP5002122B2 (en) * 2004-07-07 2012-08-15 株式会社東洋新薬 Wheat leaf processed product-containing composition
CN103743869B (en) * 2014-01-08 2015-08-12 吉林睿德生物科技有限公司 A kind of defining method improving the material of red bean blood sugar decreasing effect
WO2017047706A1 (en) * 2015-09-18 2017-03-23 株式会社林原 Inhibitor for blood glucose level increase and oral composition comprising same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57146713A (en) * 1981-03-09 1982-09-10 Akira Endo Hypoglycemic
JPS59112922A (en) * 1983-10-05 1984-06-29 Akira Endo Agent for lowering blood sugar

Also Published As

Publication number Publication date
JPS62201821A (en) 1987-09-05

Similar Documents

Publication Publication Date Title
JP4039550B2 (en) Cereal-derived physiologically active substance and method for preparing the same
JPH05504068A (en) Soluble dietary fiber composition and method for producing the same
JP3243559B2 (en) Process for producing water-soluble dietary fiber mainly composed of barley bran-derived β-glucan
JP2787252B2 (en) Colorectal cancer inhibitor
JPS626691B2 (en)
JP2544634B2 (en) How to extract hemicellulose
JPH0723315B2 (en) Blood sugar elevation inhibitor
US9314496B2 (en) Insoluble dietary fiber-containing product derived from grain seeds
US20220007693A1 (en) A process for preparation of cereal fractions
AU2010202559A1 (en) Satiety-lasting composition containing an insoluble dietary fiber derived from grain-plant seed
JPH03175951A (en) Insoluble edible fiber and same fiber-containing food
JP3191956B2 (en) Alcoholic fatty liver inhibitors
JPH0678236B2 (en) Liver function activator
JP2002097203A (en) METHOD FOR EXTRACTING beta-GLUCAN
JPS591688B2 (en) Substances that suppress serum cholesterol rise and methods for producing the same
JPH03209331A (en) Substance for improving intestinal environment
JPH045649B2 (en)
JP3641284B2 (en) Glucose tolerance disorder improving agent
JPH07121867B2 (en) Liver function activator
JPH0434527B2 (en)
JPS591689B2 (en) Serum cholesterol increase inhibitor
JP3440311B2 (en) Diuretic promoting composition
JPS63185931A (en) Removal of blood serum cholesterol rise promoting factor from wheat bran
JPH09132533A (en) Suppressant for both ulcer and hepatopathy comprising lactic acid bacterium fermentation product
AU767576B2 (en) Acid and solvent modification of psyllium

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term